BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Germ cell tumor AND TERT, EST2, Q8NG46, Q8N6C3, Q2XS35, O14783, O14746, 7015, hEST2, TCS1, TRT, TP2
933 results:

  • 1. EGFR/CEP7 high polysomy is separate and distinct from EGFR amplification in glioblastoma as determined by fluorescence in situ hybridization.
    Wilcock DM; Goold E; Zuromski LM; Davidson C; Mao Q; Sirohi D
    J Neuropathol Exp Neurol; 2024 Apr; 83(5):338-344. PubMed ID: 38605523
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Pediatric-type high-grade gliomas with PDGFRA amplification in adult patients with Li-Fraumeni syndrome: clinical and molecular characterization of three cases.
    Kibe Y; Ohka F; Aoki K; Yamaguchi J; Motomura K; Ito E; Takeuchi K; Nagata Y; Ito S; Mizutani N; Shiba Y; Maeda S; Nishikawa T; Shimizu H; Saito R
    Acta Neuropathol Commun; 2024 Apr; 12(1):57. PubMed ID: 38605367
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Trauma plays an important role in acral melanoma: A retrospective study of 303 patients.
    Huang R; Zhao M; Zhang G; Yang Y; Wang J; Zheng K; Li L; Su X; Zhao L; Wu Y; Zou Z
    Cancer Med; 2024 Apr; 13(7):e7137. PubMed ID: 38545846
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Role of Surgery in Metastatic Melanoma and Review of Melanoma Molecular Characteristics.
    Sukniam K; Manaise HK; Popp K; Popp R; Gabriel E
    Cells; 2024 Mar; 13(6):. PubMed ID: 38534309
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. High expression of RTEL1 predicates worse progression in gliomas and promotes tumorigenesis through JNK/ELK1 cascade.
    Wang G; Ren X; Li J; Cui R; Zhao X; Sui F; Liu J; Chen P; Yang Q; Ji M; Hou P; Gao K; Qu Y
    BMC Cancer; 2024 Mar; 24(1):385. PubMed ID: 38532312
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. STING is significantly increased in high-grade glioma with high risk of recurrence.
    Zhong M; Long M; Han C; Ji S; Yang Q
    Oncoimmunology; 2024; 13(1):2327682. PubMed ID: 38516268
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Predicting the prognosis of glioma patients with tert promoter mutations and guiding the specific immune profile of immune checkpoint blockade therapy.
    Cao W; Lan J; Hu C; Kong J; Xiang L; Zhang Z; Sun Y; Zeng Z; Lei S
    Aging (Albany NY); 2024 Mar; 16(6):5618-5633. PubMed ID: 38499392
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. MGMT unmethylation and high levels of CD47 and TIGIT indicate a poor prognosis in adult diffuse gliomas.
    Ma L; Shi Y; Li C; Deng B; Jiang J; Cao Y; Wang L; Li H
    Front Immunol; 2024; 15():1323307. PubMed ID: 38404571
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Sub-region based radiomics analysis for prediction of isocitrate dehydrogenase and telomerase reverse transcriptase promoter mutations in diffuse gliomas.
    Zhang H; Ouyang Y; Zhang H; Zhang Y; Su R; Zhou B; Yang W; Lei Y; Huang B
    Clin Radiol; 2024 May; 79(5):e682-e691. PubMed ID: 38402087
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Treatment outcome of IDH1/2 wildtype CNS WHO grade 4 glioma histologically diagnosed as WHO grade II or III astrocytomas.
    Keric N; Krenzlin H; Kalasauskas D; Freyschlag CF; Schnell O; Misch M; von der Brelie C; Gempt J; Krigers A; Wagner A; Lange F; Mielke D; Sommer C; Brockmann MA; Meyer B; Rohde V; Vajkoczy P; Beck J; Thomé C; Ringel F
    J Neurooncol; 2024 Mar; 167(1):133-144. PubMed ID: 38326661
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Artificial Intelligence Imaging for Predicting High-risk Molecular Markers of Gliomas.
    Liang Q; Jing H; Shao Y; Wang Y; Zhang H
    Clin Neuroradiol; 2024 Mar; 34(1):33-43. PubMed ID: 38277059
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Reliable detection of genetic alterations in cyst fluid DNA for the diagnosis of brain tumors.
    On J; Natsumeda M; Takahashi H; Koyama A; Shibuma S; Shibata N; Watanabe J; Saito S; Kanemaru Y; Tsukamoto Y; Okada M; Ogura R; Eda T; Tada M; Shimizu H; Adachi JI; Mishima K; Nishikawa R; Kakita A; Oishi M
    J Neurooncol; 2024 Jan; 166(2):273-282. PubMed ID: 38227143
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. tert promoter mutations in atypical melanocytic lesions: A series of seven cases with adverse melanoma-specific outcome.
    Huber R; Lee J; Borretta L; Tessier-Cloutier B; Lum A; Yip S; Horst BA
    Hum Pathol; 2024 Feb; 144():34-39. PubMed ID: 38224873
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Prognostic and predictive biomarkers in paediatric solid tumours.
    Glembocki AI; Somers GR
    Pathology; 2024 Mar; 56(2):283-296. PubMed ID: 38216399
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. The Biological and Clinical Role of the Telomerase Reverse Transcriptase Gene in Glioblastoma: A Potential Therapeutic Target?
    Di Nunno V; Aprile M; Bartolini S; Gatto L; Tosoni A; Ranieri L; De Biase D; Asioli S; Franceschi E
    Cells; 2023 Dec; 13(1):. PubMed ID: 38201248
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Clinical, histological, and molecular differences in melanoma due to different tert promoter mutations subtypes. A retrospective cross-sectional study in 684 melanoma patients.
    Manrique-Silva E; David ME; Maider AM; García-Casado Z; Moro R; Requena C; Través V; Virós A; Kumar R; Nagore E
    Pigment Cell Melanoma Res; 2024 May; 37(3):343-351. PubMed ID: 38153178
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Whole tumor analysis reveals early origin of the tert promoter mutation and intercellular heterogeneity in tert expression.
    Appin CL; Hong C; Suwala AK; Hilz S; Mathur R; Solomon DA; Smirnov IV; Stevers NO; Shai A; Wang A; Berger MS; Chang SM; Phillips JJ; Costello JF
    Neuro Oncol; 2024 Apr; 26(4):640-652. PubMed ID: 38141254
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. [Practical approach to molecular pathology of central nervous system tumours].
    Vida L; Horváth B; Kajtár B
    Magy Onkol; 2023 Dec; 67(4):304-313. PubMed ID: 38109509
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Static Magnetic Field Reduces Intracellular ROS Levels and Protects cells Against Peroxide-Induced Damage: Suggested Roles for Catalase.
    Frachini ECG; Silva JB; Fornaciari B; Baptista MS; Ulrich H; Petri DFS
    Neurotox Res; 2023 Dec; 42(1):2. PubMed ID: 38095761
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Live-cell imaging Unveils stimulus-specific dynamics of Nrf2 activation in UV-exposed melanoma cells: Implications for antioxidant compound screening.
    Htut NW; Onkoksoong T; Saelim M; Kueanjinda P; Sampattavanich S; Panich U
    Free Radic Biol Med; 2024 Feb; 211():1-11. PubMed ID: 38092271
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 47.